Last Price$37.9(0.2%)
Market Cap$3,476.0M
LEGN Q4’24 Earnings
| Metric | Estimates | Actuals | Surprise |
|---|---|---|---|
| Revenue | $179.0M | $186.5M | BEAT by 4.2% |
| EPS | ($0.24) | $0.14 | BEAT by 157.2% |
LEGN Historical Revenue & EPS and Expectations
1Y
3Y
5Y
10Y
Revenue
EPS
LEGN Earnings History
| Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue actual | $10.1M | $10.1M | $17.7M | $19.5M | $11.5M | $11.6M | $11.7M | $40.8M | $13.7M | $20.2M | $16.9M | $39.0M | $40.8M | $12.0M | $27.4M | $27.6M | $36.3M | $73.3M | $96.0M | $79.5M | $94.0M | $186.5M | $160.2M | $186.5M |
| Revenue estimate | N/A | N/A | N/A | N/A | N/A | $13.0M | $13.0M | $13.0M | $6,500.0K | $9,133.3K | $7,833.3K | $14.3M | $25.0M | $33.6M | $32.3M | $32.3M | $42.2M | $56.6M | $97.3M | $94.1M | $143.2M | $125.3M | $143.9M | $179.0M |
| Revenue surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 10.8% | 9.6% | 213.7% | 110.5% | 121.5% | 115.5% | 173.3% | 63.3% | 64.4% | 15.4% | 14.6% | 13.8% | 29.5% | 1.3% | 15.5% | 34.4% | 48.9% | 11.3% | 4.2% |
| EPS actual | ($0.12) | ($0.29) | ($0.28) | ($0.64) | ($0.34) | ($1.25) | ($0.50) | ($0.44) | ($0.61) | ($0.66) | ($0.87) | ($0.60) | ($0.27) | ($1.25) | ($0.27) | ($0.85) | ($0.68) | ($1.14) | ($0.34) | ($0.80) | ($0.33) | ($0.10) | $0.00 | $0.14 |
| EPS estimate | N/A | N/A | N/A | N/A | N/A | ($0.26) | ($0.31) | ($0.28) | ($0.35) | ($0.34) | ($0.42) | ($0.34) | ($0.36) | ($0.31) | ($0.37) | ($0.37) | ($0.42) | ($0.36) | ($0.31) | ($0.36) | ($0.19) | ($0.29) | ($0.33) | ($0.24) |
| EPS surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 380.8% | 63.0% | 55.3% | 74.3% | 97.0% | 109.3% | 75.5% | 24.7% | 303.0% | 27.7% | 127.7% | 62.9% | 215.9% | 9.6% | 125.0% | 70.6% | 65.3% | 100.0% | 157.2% |
LEGN Price Change after Earnings
Crunching data... Almost there!
LEGN Recent Quarter Financial Statements Overview
Income statement
Balance sheet
Cash Flow statement
Competing with LEGN Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Revenue | EPS | Last quarter Revenue growth | Last quarter EPS growth | Last quarter Revenue surprise | Last quarter EPS surprise | Next quarter Revenue growth | Next quarter EPS growth | Last 10 Earnings (how many miss vs beat) | 1Y Fwd Revenue growth | 1Y Fwd EPS growth |
$3,476.0M | $627.2M | ($0.29) | 134.7% | N/A | Beat by 4.2% | Miss by 157.2% | 5.7% | (234.6%) | Beats: 9 Misses: 1 | 116.3% | (70.7%) | |
$132.4B | $11.0B | ($2.06) | 15.7% | (5.6%) | Beat by 8.4% | Miss by 12.9% | (1.7%) | 20.2% | Beats: Misses: | 8.6% | (962.4%) | |
$72.4B | $14.2B | $40.88 | 10.3% | (21.6%) | Beat by 3.1% | Miss by 27.1% | (10.2%) | 9.3% | Beats: 8 Misses: 2 | 2.4% | 3.1% | |
$36.9B | $3,154.8M | $11.71 | 219.9% | N/A | Beat by 84.8% | Beat by 581.0% | (45.6%) | (83.5%) | Beats: 7 Misses: 3 | 76.3% | (132.2%) | |
$32.2B | $2,248.2M | ($2.17) | 34.9% | (40.9%) | Beat by 11.3% | Miss by 29.1% | (0.4%) | 45.9% | Beats: 8 Misses: 2 | 28.6% | (26.5%) | |
$23.9B | €2,751.1M | (€3.84) | (19.5%) | (100.0%) | Beat by 5.2% | Miss by 100.0% | (79.9%) | 0.0% | Beats: 5 Misses: 5 | (28.0%) | (182.9%) | |
$14.9B | $2,263.9M | $2.31 | (0.3%) | (58.6%) | Miss by 14.8% | Miss by 50.4% | 22.5% | 132.0% | Beats: 5 Misses: 5 | 35.4% | 144.6% | |
$14.6B | $0.0 | ($0.31) | (100.0%) | 62.6% | undefinedN/A | undefinedN/A | 0.0% | (8.4%) | Beats: 6 Misses: 4 | N/A | 11.4% | |
$14.4B | $2,877.4M | $26.45 | 19.7% | 45.9% | Beat by 1.8% | Beat by 3.3% | (0.9%) | (3.0%) | Beats: 7 Misses: 3 | 9.1% | 6.8% | |
$13.7B | $2,850.5M | $2.25 | 15.6% | 490.9% | Beat by 6.2% | Beat by 22.4% | (0.9%) | 7.4% | Beats: 8 Misses: 2 | 10.0% | 48.9% |
FAQ
1. When was Legend Biotech Corporation's last earnings date?
Legend Biotech Corporation's last earnings date was Sep'24 (Q4 2024).
2. What is Legend Biotech Corporation's EPS, and was there a surprise?
Legend Biotech Corporation's EPS was $0.14, with a 157.2% beat.
3. What is Legend Biotech Corporation's revenue, and was there a surprise?
Legend Biotech Corporation's revenue was $186.5M, with a 4.2% beat.
4. What is Legend Biotech Corporation's next quarter EPS estimate?
Legend Biotech Corporation's next quarter EPS estimate is ($0.39), with an expected (2.5%) YoY growth.